Benzinga's Top Upgrades, Downgrades For April 5, 2017

Top Upgrades

  • Argus upgraded Wynn Resorts, Limited WYNN from Hold to Buy. Wynn Resorts shares rose 0.91 percent to $117.80 in pre-market trading.
  • Keefe Bruyette & Woods upgraded Wells Fargo & Co WFC from Market Perform to Outperform. Wells Fargo shares rose 0.78 percent to $55.63 in pre-market trading.
  • Analysts at CIBC upgraded TELUS Corporation (USA) TU from Neutral to Outperform. Telus shares rose 0.77 percent to close at $32.64 on Tuesday.
  • Nomura upgraded Patterson-UTI Energy, Inc. PTEN from Neutral to Buy. Patterson-UTI Energy shares rose 0.79 percent to close at $24.35 on Tuesday.
  • Analysts at JP Morgan upgraded McCormick & Company, Incorporated MKC from Underweight to Neutral. McCormick shares gained 0.28 percent to close at $98.42 on Tuesday.
  • Nomura upgraded Nabors Industries Ltd. NBR from Neutral to Buy. Nabors Industries shares gained 3.01 percent to $13.68 in pre-market trading.
  • Analysts at Wells Fargo upgraded Autoliv Inc. ALV to Outperform. Autoliv shares rose 0.74 percent to $98.20 in pre-market trading.
  • Analysts at Keefe Bruyette & Woods upgraded Citigroup Inc C from Market Perform to Outperform. Citigroup shares gained 1.21 percent to $60.40 in pre-market trading.
  • Analysts at Goldman Sachs upgraded PBF Energy Inc PBF from Sell to Neutral. PBF Energy shares fell 0.27 percent to close at $21.93 on Tuesday.


Top Downgrades

  • Analysts at CIBC downgraded Rogers Communications Inc. (USA) RCI from Outperform to Neutral. Rogers Communication shares rose 0.57 percent to close at $44.38 on Tuesday.
  • Cowen & Co. downgraded Novartis AG (ADR) NVS from Outperform to Market Perform. Novartis shares fell 1.04 percent to $73.99 in pre-market trading.
  • Analysts at Goldman Sachs downgraded Acuity Brands, Inc. AYI from Buy to Neutral. Acuity Brands shares fell 14.77 percent to close at $173.93 on Tuesday.
  • KeyBanc downgraded Generac Holdings Inc. GNRC from Overweight to Sector Weight. Generac shares dropped 0.30 percent to close at $36.92 on Tuesday.
  • Analysts at Jefferies downgraded Amgen, Inc. AMGN from Buy to Hold. Amgen shares rose 0.29 percent to close at $164.36 on Tuesday.
  • Wells Fargo downgraded Exelon Corporation EXC from Outperform to Market Perform. Exelon shares rose 0.89 percent to close at $36.14 on Tuesday.
  • Goldman Sachs downgraded Imperial Oil Ltd (USA) IMO from Neutral to Sell. Imperial Oil shares rose 0.16 percent to $30.79 in pre-market trading.


Top Initiations

  • Analysts at Evercore ISI Group initiated coverage on Booz Allen Hamilton Holding Corporation BAH with an In-Line rating. The price target for Booz Allen is set to $38. Booz Allen shares closed at $34.97 on Tuesday.
  • Analysts at Cowen & Co. initiated coverage on Neos Therapeutics Inc NEOS with an Outperform rating. The price target for Neos Therapeutics is set to $20. Neos Therapeutics shares closed at $7.20 on Tuesday.
  • Analysts at Evercore ISI Group initiated coverage on CSRA Inc CSRA with an Outperform rating. The price target for CSRA is set to $34. CSRA shares closed at $27.95 on Tuesday.
  • Analysts at B. Riley initiated coverage of Acacia Communications, Inc. ACIA with a Neutral rating. The price target for Acacia Communications is set to $60. Acacia Communications shares closed at $58.74 on Tuesday.
  • Analysts at Deutsche Bank initiated coverage of Humana Inc HUM with a Hold rating. The price target for Humana is set to $216. Humana shares closed at $211.05 on Tuesday.
  • Analysts at Deutsche Bank initiated coverage on UnitedHealth Group Inc UNH with a Buy rating. The price target for UnitedHealth is set to $183. UnitedHealth shares closed at $164.97 on Tuesday.
  • JMP Securities initiated coverage on istar Inc STAR with a Market Perform rating. istar shares closed at $11.55 on Tuesday.
  • Analysts at Wells Fargo initiated coverage on Merit Medical Systems, Inc. MMSI with an Outperform rating. Merit Medical shares closed at $28.20 on Tuesday.
  • Analysts at Deutsche Bank initiated coverage on Centene Corp CNC with a Buy rating. The price target for Centene is set to $84. Centene shares closed at $69.77 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationAnalyst RatingsCommunications EquipmentDowngradesEnergyInformation TechnologyInitiationsOil & Gas Drillingtop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!